产品名称：Human IL-23P19 Antibody (Tildrakizumab, Research Use)
产品编号：NBR-0221
针对靶点：IL-23P19
抗体药商品名：Tildrakizumab
抗体药描述：Tildrakizumab, sold under the brand names Ilumya and Ilumetri, is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.Tildrakizumab was designed to block interleukin-23 (IL-23), a cytokine that plays a key role in managing the immune system and autoimmune disease. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: IL-23P19
Synonyms: IL-23; IL-23A; IL23P19; P19; SGRF
Target Description: Associates with IL12B to form the pro-inflammatory cytokine IL-23 that plays different roles in innate and adaptive immunity.
Ensembl: ENSG00000110944 
Uniprot: Q9NPF7